Literature DB >> 25269853

Preventive letter: doubling the return rate after gestational diabetes mellitus.

Pablo R Olmos1, Gisella R Borzone, Loni Berkowitz, Nicolás Mertens, Dolores Busso, José L Santos, José A Poblete, Claudio Vera, Cristián Belmar, Denisse Goldenberg, Bárbara Samith, Ana M Acosta, Manuel Escalona.   

Abstract

To measure the impact of a "Preventive Letter" designed to encourage the return of gestational diabetes mellitus (GDM) mothers to follow up visit after delivery, in the context of a worldwide concern about low return rates after delivery of these patients. Mothers with GDM require medical evaluation and an oral glucose tolerance test (OGTT) 6 weeks after delivery, in order to: [a] confirm remission of GDM and [b] provide advice on the prevention of type 2 diabetes. In the year 2003 we developed a "Preventive Letter", containing three aspects: [a] current treatment, [b] suggested management during labor, and [c] a stapled laboratory order for OGTT to be performed 6 weeks after delivery. The return rate after delivery was assessed in two groups of GDM mothers: [a] "Without Preventive Letter" (n = 253), and "With Preventive Letter" (n = 215). Both groups, similar with respect to age (33.0 ± 5.4 and 32.3 ± 4.9 years respectively, p = 0.166) and education time (14.9 ± 1.8 and 15.0 ± 1.8 years respectively, p = 0.494), showed a significant difference in the 1-year return rate after delivery, as assessed by the Kaplan-Meier test: 32.0 % for the group "Without Preventive Letter", and 76.0 % for the group "With Preventive Letter" (p < 0.001). The 1-year return rate after delivery of GDM mothers was 2.4 times higher in the group "With Preventive Letter" than in the group without it. We believe that this low-cost approach could be useful in other institutions caring for pregnant women with diabetes.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25269853     DOI: 10.1007/s10995-014-1614-9

Source DB:  PubMed          Journal:  Matern Child Health J        ISSN: 1092-7875


  7 in total

1.  Gestational diabetes and pre-pregnancy overweight: possible factors involved in newborn macrosomia.

Authors:  Pablo Roberto Olmos; Gisella Rosa Borzone; Roberto Ignacio Olmos; Claudio Nicolás Valencia; Felipe Andrés Bravo; María Isabel Hodgson; Cristián Gastón Belmar; José Andrés Poblete; Manuel Orlando Escalona; Bernardita Gómez
Journal:  J Obstet Gynaecol Res       Date:  2011-11-09       Impact factor: 1.730

Review 2.  Postpartum screening following GDM: how well are we doing?

Authors:  Kelly J Hunt; Sarah L Logan; Deborah L Conway; Jeffrey E Korte
Journal:  Curr Diab Rep       Date:  2010-06       Impact factor: 4.810

3.  Postpartum diabetes screening in women with a history of gestational diabetes.

Authors:  Karen V Smirnakis; Lisa Chasan-Taber; Myles Wolf; Glenn Markenson; Jeffrey L Ecker; Ravi Thadhani
Journal:  Obstet Gynecol       Date:  2005-12       Impact factor: 7.661

Review 4.  Original research: postpartum testing rates among women with a history of gestational diabetes--systematic review.

Authors:  Michael P Carson; Matthew I Frank; Erin Keely
Journal:  Prim Care Diabetes       Date:  2013-05-15       Impact factor: 2.459

Review 5.  Gestational diabetes mellitus and subsequent development of overt diabetes mellitus.

Authors:  P Damm
Journal:  Dan Med Bull       Date:  1998-11

6.  Impact of health beliefs, social support and self-efficacy on physical activity and dietary habits during the post-partum period after gestational diabetes mellitus: study protocol.

Authors:  Barbara Kaiser; Chantal Razurel; Emilien Jeannot
Journal:  BMC Pregnancy Childbirth       Date:  2013-06-21       Impact factor: 3.007

7.  The DIAMIND study: postpartum SMS reminders to women who have had gestational diabetes mellitus to test for type 2 diabetes: a randomised controlled trial - study protocol.

Authors:  Emer Heatley; Philippa Middleton; William Hague; Caroline Crowther
Journal:  BMC Pregnancy Childbirth       Date:  2013-04-12       Impact factor: 3.007

  7 in total
  1 in total

Review 1.  How do reminder systems in follow-up screening for women with previous gestational diabetes work? - a realist review.

Authors:  Jane Hyldgaard Nielsen; G J Melendez-Torres; Torill Alise Rotevatn; Kimberly Peven; Kirsten Fonager; Charlotte Overgaard
Journal:  BMC Health Serv Res       Date:  2021-06-01       Impact factor: 2.655

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.